New COVID model predicts over 1 million deaths in China through 2023
Send a link to a friend
[December 17, 2022]
By Julie Steenhuysen and Deena Beasley
CHICAGO (Reuters) - China's abrupt lifting of stringent COVID-19
restrictions could result in an explosion of cases and over a million
deaths through 2023, according to new projections from the U.S.-based
Institute of Health Metrics and Evaluation (IHME).
According to the group's projections, cases in China would peak around
April 1, when deaths would reach 322,000. About a third of China's
population will have been infected by then, IHME Director Christopher
Murray said.
China's national health authority has not reported anyofficial COVID
deaths since the lifting of COVID restrictions. The last official deaths
were reported on Dec. 3.
Total pandemic fatalities stand at 5,235.
China lifted some of the world's toughest COVID restrictions in December
after unprecedented public protests and is now experiencing a spike in
infections, with fears COVID could sweep across its 1.4 billion
population during next month's Lunar New Year holiday.
"Nobody thought they would stick to zero-COVID as long as they did,"
Murray said on Friday when the IHME projections were released online.
China's zero-COVID policy may have been effective at keeping earlier
variants of the virus at bay, but the high transmissibility of Omicron
variants made it impossible to sustain, he said.
The independent modeling group at the University of Washington in
Seattle, which has been relied on by governments and companies
throughout the pandemic, drew on provincial data and information from a
recent Omicron outbreak in Hong Kong.
"China has since the original Wuhan outbreak barely reported any deaths.
That is why we looked to Hong Kong to get an idea of the infection
fatality rate," Murray said.
For its forecasts, IHME also uses information on vaccination rates
provided by the Chinese government as well as assumptions on how various
provinces will respond as infection rates increase.
Other experts expect some 60% of China's population will eventually be
infected, with a peak expected in January, hitting vulnerable
populations, such as the elderly and those with pre-existing conditions,
the hardest.
[to top of second column]
|
A medical worker hands fever medicine to
a resident at a makeshift fever clinic set up inside a stadium, amid
the coronavirus disease (COVID-19) outbreak in Beijing, China
December 14, 2022. China Daily via REUTERS
Key concerns include China's large pool of susceptible individuals,
the use of less effective vaccines and low vaccine coverage among
those 80 and older, who are at greatest risk of severe disease.
OTHER MODELS
Disease modelers at the University of Hong Kong predict that lifting
COVID restrictions and simultaneously reopening all provinces in
December 2022 through January 2023 would result in 684 deaths per
million people during that timeframe, according to a paper released
on Wednesday on the Medrxiv preprint server that has yet to undergo
peer review.
Based on China's population of 1.41 billion, and without measures
such as a mass vaccination booster campaign, that amounts to 964,400
deaths.
Another study published July 2022 in Nature Medicine by researchers
at the School of Public Health at Fudan University in Shanghai
predicted an Omicron wave absent restrictions would result in 1.55
million deaths over a six month period, and peak demand for
intensive care units of 15.6 times higher than existing capacity.
Yanzhong Huang, a senior fellow for global health at the Council on
Foreign Relations, said there are 164 million people in China with
diabetes, a risk factor for poor COVID outcomes. There are also 8
million people aged 80 and older who have never been vaccinated.
Chinese officials are now encouraging individuals to get boosted
from a list of newer Chinese-made shots, however, the government is
still reluctant to use foreign vaccines, Huang said.
China's National Health Commission said on Friday it wasramping up
vaccinations and building stocks of ventilators andessential drugs.
(Additional reporting from Deena Beasley in Los Angeles; editing by
Caroline Humer and Michael Perry)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |